Mayukh Sukhatme
2022
In 2022, Mayukh Sukhatme earned a total compensation of $48.9M as President and Chief Investment Officer at Roivant Sciences Ltd., a 180% increase compared to previous year.
Compensation breakdown
| Bonus | $1,243,500 |
|---|---|
| Option Awards | $47,206,737 |
| Salary | $450,000 |
| Other | $25,346 |
| Total | $48,925,582 |
Sukhatme received $47.2M in option awards, accounting for 96% of the total pay in 2022.
Sukhatme also received $1.2M in bonus, $450K in salary and $25.3K in other compensation.
Rankings
In 2022, Mayukh Sukhatme's compensation ranked 13th out of 5,457 executives tracked by ExecPay. In other words, Sukhatme earned more than 99.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 13 out of 5,457 | 100th |
Division Manufacturing | 5 out of 2,958 | 100th |
Major group Chemicals And Allied Products | 2 out of 1,324 | 100th |
Industry group Drugs | 2 out of 1,227 | 100th |
Industry Pharmaceutical Preparations | 2 out of 884 | 100th |
Source: SEC filing on July 31, 2023.
Sukhatme's colleagues
We found two more compensation records of executives who worked with Mayukh Sukhatme at Roivant Sciences Ltd. in 2022.